| pubmed-article:20231531 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0011065 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0033085 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C0288171 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C2700378 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:20231531 | lifeskim:mentions | umls-concept:C1513371 | lld:lifeskim |
| pubmed-article:20231531 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20231531 | pubmed:dateCreated | 2010-3-30 | lld:pubmed |
| pubmed-article:20231531 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:abstractText | The mode of death has been well characterized in patients with heart failure and a reduced ejection fraction; however, less is known about the mode of death in patients with heart failure and a preserved ejection fraction (HFPEF). The purpose of this study was to examine the mode of death in patients with HFPEF enrolled in the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial and to determine whether irbesartan altered the distribution of mode of death in HFPEF. | lld:pubmed |
| pubmed-article:20231531 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20231531 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20231531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20231531 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20231531 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20231531 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:McKelvieRober... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:MassieBarry... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:ZileMichael... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:GaaschWilliam... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:MillerAlan... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:HaassMarkusM | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:TeerlinkJohn... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:WhiteMichelM | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:LittleWilliam... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:AnandInder... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:McMurrayJohn... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:KomajdaMichel... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:CarsonPeter... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:Lopez-SendonJ... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:PtaszynskaAga... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:HetzelScott... | lld:pubmed |
| pubmed-article:20231531 | pubmed:author | pubmed-author:I-Preserve... | lld:pubmed |
| pubmed-article:20231531 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20231531 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:20231531 | pubmed:volume | 121 | lld:pubmed |
| pubmed-article:20231531 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20231531 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20231531 | pubmed:pagination | 1393-405 | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:meshHeading | pubmed-meshheading:20231531... | lld:pubmed |
| pubmed-article:20231531 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20231531 | pubmed:articleTitle | Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. | lld:pubmed |
| pubmed-article:20231531 | pubmed:affiliation | RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Division of Cardiology, Department of Medicine, Charleston, SC 29425, USA. zilem@musc.edu | lld:pubmed |
| pubmed-article:20231531 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20231531 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:20231531 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:20231531 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20231531 | lld:pubmed |
